drugset / Trial / NCT04554433

New Treatment for COVID-19 Using Ethanol Vapor Inhalation .

NCT04554433

Phase 3 Unknown 80 enrolled Mansoura University
RandomizedParallel-groupOpen-labelTreatment

Summary

Since ARDS is a major complication of COVID - 19 with subsequent formation of non-cardiogenic pulmonary edema , worsening the oxygenation of the patients and foamy and even bloody sputum formation, so the idea is to use alcohol inhalation as it reduce surface tension on the alveoli and markedly decrease sputum formation with improvement on oxygenation beside its cytolethal effect on virus lipid bilayer. A lot of researches and publications proved the role of alcohol inhalation in treatment of pulmonary edema. Alcohol inhalation may has inflammatory effect and dangerous effect on patients but this can be controlled by the actual concentration used and the way we use it according to general condition of the patient and with the help of anti - inflammatory action of Asprin .

Timeline

Start
2020-12-01
Primary completion
2021-10-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alcohol Other / unclassified Intranasal
Comparator Aspirin Small molecule Oral

Indications